Another Hegseth aide exits as Pentagon churn continues
Justin Fulcher, who was named a senior adviser to the defense secretary in late April, said in a text message to The Washington Post that his departure is 'perfectly amicable' and that he planned all along to complete just six months of government service. He said he is grateful to Hegseth, President Donald Trump 'and to the extraordinary civilians and service members who turn vision into action every day.'
'Working alongside the dedicated men and women of the Department of Defense has been incredibly inspiring,' Fulcher said.
Sean Parnell, a Pentagon spokesman, acknowledged Fulcher's departure in a text message, after CBS News first reported that Fulcher had been fired. Parnell said it was 'not fair' to characterize the exit as a firing and called Fulcher a 'great guy.'
The Pentagon also issued a short statement from Parnell that said the Defense Department is grateful to Fulcher 'for his work on behalf of President Trump and Secretary Hegseth. We wish him well in his future endeavors.'
Hegseth, a former Fox News personality, came to the Cabinet job with little prior managerial experience and has struggled to achieve cohesion among his inner circle of aides. The staff churn, along with Hegseth's other early missteps, has drawn sharp scrutiny from Congress and, at times, the White House.
The latest shake-up follows a report by The Post published Tuesday that detailed an unusual situation ahead of his appointment in April in which Fulcher — then a member of billionaire Elon Musk's U.S. DOGE Service — stormed out of a meeting with the Pentagon's DOGE team lead, Yinon Weiss, and sought help from Hegseth's front office.
As The Post reported, Fulcher told Hegseth and other senior officials in the secretary's office that he thought the Pentagon Force Protection Agency, an internal police and security organization, was looking for him. That upset Hegseth, who then summoned Weiss to his office and confronted him, raising his voice at times, people familiar with the altercation said.
Weiss, a tech entrepreneur who had just taken over as the Pentagon's DOGE team lead, denied having called law enforcement, telling Hegseth that instead he had reported Fulcher to a government official with the Defense Department transition office that assists newly arriving political appointees, a person familiar with the encounter said.
Hegseth brought Fulcher onto his team days later, after he fired three other senior advisers and accused them of leaking information to the news media. They have emphatically denied the accusation, and the Pentagon has disclosed no evidence backing the allegations.
Fulcher was embroiled in additional controversy last month after the Guardian reported that he told Hegseth's personal attorney, Tim Parlatore, and Hegseth's chief of staff at the time, Joe Kasper, that he knew of surveillance measures that could be used to find leakers in the Pentagon.
Fulcher joined Parlatore in the search for suspected leakers, but officials at the White House and in the Pentagon later determined that Fulcher had exaggerated his usefulness and the purported evidence he had alluded to did not exist, people familiar with the matter said. In light of that, some of Hegseth's other advisers began to cast doubt on Fulcher's standing in the administration.
Within the Pentagon, there was speculation for days that Fulcher's departure was imminent, but on July 11 administration officials said in a statement to The Post that he was still a senior adviser to the secretary and gave no indication that was changing. Fulcher, too, said then that he was still on the team without disclosing that he would be leaving soon.
Fulcher's workspace had recently been relocated outside of Hegseth's main office to a desk down the hall, but he previously told The Post the move was temporary and occurring because of maintenance work. Others familiar with the situation affirmed that the move appeared to be temporary, but some said that it had raised new questions as Hegseth has worked to suppress any perception of persistent dysfunction.
Other members of Hegseth's team who have departed include Dan Caldwell, Colin Carroll and Darin Selnick, the three fired in April; Kasper, who voluntarily left his role for the private sector that month, and John Ullyot, who served for a few months as the Pentagon's top spokesman.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a few seconds ago
- Yahoo
Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT
Exelixis, Inc. (NASDAQ:EXEL) is one of the most profitable biotech stocks to invest in now. On July 22, Morgan Stanley analyst Sean Laaman maintained a Buy rating on Exelixis, Inc. (NASDAQ:EXEL) and set a price target of $48.00. A team of scientists in lab coats surrounded by pharmaceuticals and medical equipment, researching a life-saving oncology-focused biotechnology. The analyst reasoned that Exelixis, Inc. (NASDAQ:EXEL) recently updated its 2025 revenue guidance, increasing it to a $2.25-2.35 billion range after the higher-than-expected sales of Cabo. He attributed this optimistic outlook to the persistent demand growth and new patient starts in first-line renal cell carcinoma (1L RCC). Laaman also stated that Exelixis, Inc. (NASDAQ:EXEL) reported that it may update its guidance further as the NET launch progresses and additional revenue opportunities become clearer. Exelixis, Inc. (NASDAQ:EXEL) discovers, develops, and commercializes new medicines for difficult-to-treat cancers. Its product portfolio includes cabometyx, cometriq, and cotellic. While we acknowledge the potential of EXEL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
a few seconds ago
- Yahoo
The Open Group Launches The Open Group Open Digital Transformation™ Forum
Standards body aims to spur faster, more effective transformation initiatives SAN FRANCISCO, July 28, 2025--(BUSINESS WIRE)--The Open Group, the vendor-neutral technology consortium, has today announced the formation of The Open Group Open Digital Transformation™ Forum (ODXF). This new initiative will support enterprise Digital Transformation by developing and popularizing pragmatic, open standards in this increasingly valuable and challenging space. By establishing clear guidelines for Digital Transformation initiatives and enabling cross-industry collaboration to share insights and best practices, ODXF aims to ensure that a greater share of Digital Transformation investment globally delivers effective returns on investment and measurably positive impacts on cultural, workforce, and technological changes. "The vast majority of enterprises today are engaged in Digital Transformation initiatives, with significant global spend in Digital Transformation," commented Rashed Al-Yami, Governing Board Member of The Open Group and Manager Digital Platforms & Architecture Design Division at Aramco. "By developing open standards through vendor-neutral collaboration, ODXF can influence the Digital Transformation agenda towards more rigorous and successful practices." Key focus areas for ODXF include developing standardized frameworks for Digital Transformation initiatives, ensuring consistency, and producing reference architectures which organizations can incorporate in order to make their own Digital Transformation journeys more agile and responsive. The Forum will also collaborate on establishing a body of knowledge, which incorporates a range of documents designed to help users operationalize the standard, as well as ultimately delivering a certification program for practitioners to demonstrate that they understand and can apply best-in-class approaches to Digital Transformation. "Digital Transformation is not a new term, but the emergence of a range of disruptive technologies, from AI to quantum computing, has made it more urgent than ever for businesses to find a clear guiding path towards proven approaches to this challenge," said Steve Nunn, President and CEO of The Open Group. "Our track record of bringing industry stakeholders together in a neutral, collaborative space means that The Open Group is well placed to add value to one of the world's major areas of investment." To learn more about The Open Group Open Digital Transformation Forum, please visit here. About The Open Group The Open Group is a global consortium that enables the achievement of business objectives through technology standards and open source initiatives by fostering a culture of collaboration, inclusivity, and mutual respect among our diverse group of 900+ memberships. Our Membership includes customers, systems and solutions suppliers, tool vendors, integrators, academics, and consultants across multiple industries. View source version on Contacts Media contact Monika BoudovaHotwire for The Open GroupUKOpengroup@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a few seconds ago
- Yahoo
RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)
Abbott Laboratories (NYSE:ABT) ranks among the . RBC Capital maintained its Outperform rating on Abbott Laboratories (NYSE:ABT) on July 15 and raised its price target from $145 to $147. The firm pointed to Abbott's strong single-digit revenue and double-digit EPS growth potential as examples of its ability to provide top-tier financial growth in the medical technology industry. According to RBC Capital's intra-quarter checks, Abbott Laboratories (NYSE:ABT) maintains positive healthcare utilization in Q2. Moreover, Abbott's diabetes brand, which has been attracting a lot of investor interest, was one of the several growth catalysts mentioned in the firm's report. The less elective nature of Abbott's medical device portfolio was also mentioned by RBC as a benefit. RBC Capital's sustained belief in Abbott Laboratories (NYSE:ABT) as the best-performing large cap in its coverage year-to-date is bolstered by other positives such as business momentum in diabetes care, favorable trends in diagnostics, stability in nutrition, and strength in established pharmaceuticals. Abbott Laboratories (NYSE:ABT) is a leading global healthcare company that manufactures a wide range of branded generic medications, medical devices, diagnostics, and nutritional items. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio